---
name: Fujifilm Pharmaceuticals U.S.A., Inc
slug: fujifilmpharma
site: cdmo
website_domain: fujifilmpharma.com
summary: CDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities.
tagline: Liposome and LNP CDMO with bench-to-commercial GMP manufacturing and mRNA expertise.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: 
tier2_domain_verified: false
updated_at: 2026-07-26T07:01:07.537Z
services_count: 9
modalities_count: 2
indications_count: 2
locations_count: 0
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Fujifilm Pharmaceuticals U.S.A., Inc

Liposome and LNP CDMO with bench-to-commercial GMP manufacturing and mRNA expertise.

Listed on cdmo.directory.

## Summary

CDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities.

## Services

- Formulation Development
- Process Development
- Lipid Nanoparticle (LNP) Formulation
- mRNA Manufacturing
- Upstream Processing
- Downstream Processing
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Technology Transfer

## Modalities

- mRNA
- Oligonucleotide

## Indications

- Oncology
- Infectious Disease

## Long description

FUJIFILM Pharmaceuticals U.S.A., Inc is a contract development and manufacturing organization (CDMO) providing integrated drug delivery and manufacturing services. The company specializes in:

**Core Capabilities:**
- Liposome formulation design, process development, and scale-up manufacturing with high-potency API handling
- Lipid nanoparticle (LNP) bench-to-commercial scale manufacturing for improved efficacy and safety
- mRNA process development and scale-up expertise
- GMP manufacturing with upstream and downstream processing, aseptic fill-and-finish, and batch release testing
- Proprietary ionizable lipid library for pH-responsive nucleic acid delivery

**Service Scope:**
One-stop service provider offering formulation development tailored to project phase, from small-scale research through commercial manufacturing. The company leverages Fujifilm's global expertise in nano drug delivery technologies and life science solutions to support therapeutic development from discovery through commercialization.

## Related companies

- [BioVectra](/companies/biovectra) (Formulation Development, Process Development) — [Compare](/compare/biovectra/fujifilmpharma)
- [Samsung Biologics](/companies/samsungbiologics) (Formulation Development, Process Development) — [Compare](/compare/fujifilmpharma/samsungbiologics)
- [Curia](/companies/curiaglobal) (Formulation Development, Process Development) — [Compare](/compare/curiaglobal/fujifilmpharma)
- [TriLink BioTechnologies](/companies/trilinkbiotech) (Process Development, mRNA Manufacturing) — [Compare](/compare/fujifilmpharma/trilinkbiotech)
- [National Resilience](/companies/resilience) (Formulation Development, Process Development) — [Compare](/compare/fujifilmpharma/resilience)
- [AGC Biologics](/companies/agcbio) (Formulation Development, Process Development) — [Compare](/compare/agcbio/fujifilmpharma)
- [Aldevron](/companies/aldevron) (Process Development, Lipid Nanoparticle (LNP) Formulation) — [Compare](/compare/aldevron/fujifilmpharma)
- [Forge Biologics](/companies/forgebiologics) (Process Development, Upstream Processing) — [Compare](/compare/forgebiologics/fujifilmpharma)

_Profile last updated: 2026-07-26T07:01:07.537Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.